CHRONIC GRAFT VERSUS HOST DISEASE side effect
What is CHRONIC GRAFT VERSUS HOST DISEASE ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
CHRONIC GRAFT VERSUS HOST DISEASE and Recently Reported Side Effects
CHRONIC GRAFT VERSUS HOST DISEASE and 15 most Active Side Effect polls
CHRONIC GRAFT VERSUS HOST DISEASE and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with CHRONIC GRAFT VERSUS HOST DISEASE
ALEMTUZUMAB BUSULFAN BUSULFEX CAMPATH CISPLATIN CYCLOPHOSPHAMIDE CYCLOSPORINE ELSPAR FLUDARABINE MAB METHOTREXATE METHYLPREDNISOLO MYCOPHENOLATE MYLOTARG NEORAL PHENYTOIN PREDNISOLONE PROGRAF SANDIMMUNE TAZOCILLINE VANCOMYCINMab Side Effects Report #5657072-6
Consumer or non-health professional from MEXICO reported MAB CAMPATH problem on Feb 19, 2008. Male patient, 15 years of age, was diagnosed with acute graft versus host disease, pneumocystis jiroveci pneumonia, antifungal prophylaxis, antiviral prophylaxis, prophylaxis against graft versus host disease and was treated with MAB CAMPATH. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, . MAB CAMPATH dosage: unknown. During the same period patient was treated with TRIMETHOPRIM, FLUCONAZOLE, ACYCLOVIR, ITRACONAZOLE, METHOTREXATE. Patient died.
Cyclosporine Side Effects Report #5659497-1
CYCLOSPORINE problem was reported by a Health Professional from TURKEY on Feb 29, 2008. Male patient, 44 years of age, was diagnosed with stem cell transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, diarrhoea, pneumocystis jiroveci infection, respiratory failure, skin depigmentation, skin exfoliation, skin hyperpigmentation, vitiligo, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULPHAN, CYCLOPHOSPHAMIDE. Patient died.
Mab Side Effects Report #5661798-8
Consumer or non-health professional from MEXICO reported MAB CAMPATH problem on Feb 19, 2008. Male patient, 15 years of age, was diagnosed with acute graft versus host disease, pneumocystis jiroveci pneumonia, antifungal prophylaxis, antiviral prophylaxis, prophylaxis against graft versus host disease and was treated with MAB CAMPATH. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, . MAB CAMPATH dosage: unknown. During the same period patient was treated with TRIMETHOPRIM, FLUCONAZOLE, ACYCLOVIR, ITRACONAZOLE, METHOTREXATE. Patient died.
Methylprednisolo Side Effects Report #5618528-5
METHYLPREDNISOLONE problem was reported by a Consumer or non-health professional from JAPAN on Jan 09, 2008. Female patient, child 1 years of age, was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, cytomegalovirus infection, haemolytic anaemia, thrombocytopenic purpura, . METHYLPREDNISOLONE dosage: unknown. During the same period patient was treated with BUSULFAN, FLUDARABINE, ANTILYMPHOCYTE IMMUNOGLOBULIN, CYCLOSPORINE. Patient recovered.
Alemtuzumab Side Effects Report #5629377-6
Health Professional from MEXICO reported ALEMTUZUMAB problem on Feb 05, 2008. Male patient, 15 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, CORTICOSTEROIDS, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
Alemtuzumab Side Effects Report #5631858-6
ALEMTUZUMAB problem was reported by a Health Professional from MEXICO on Feb 05, 2008. Male patient, 15 years of age, was diagnosed with graft versus host disease, bone marrow conditioning regimen, prophylaxis against graft versus host disease, antifungal prophylaxis, antiviral prophylaxis and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, . ALEMTUZUMAB dosage: AS USED: 10 MG. During the same period patient was treated with FLUDARABINE, CYCLOSPORINE, METHOTREXATE, CORTICOSTEROIDS, TRIMETHOPRIM, FLUCONAZOLE, ITRACONAZOLE, ACYCLOVIR. Patient died.
Methotrexate Side Effects Report #5633873-5
Consumer or non-health professional from reported METHOTREXATE problem on Feb 19, 2008. Female patient, 39 years of age, was diagnosed with prophylaxis against graft versus host disease, leukaemia plasmacytic, bone marrow conditioning regimen and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, deafness neurosensory, ear pain, facial palsy, plasmacytoma, vertigo, vestibular disorder, vomiting, . METHOTREXATE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYCLOSPORINE, VINCRISTINE, DOXORUBICIN, MELPHALAN. Patient recovered.
Cyclophosphamide Side Effects Report #5488084-3
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 08, 2007. Female patient, 17 years of age, was diagnosed with chronic myeloid leukaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, headache, hyperthyroidism, hypothyroidism, inflammation, nausea, neck pain, tachycardia, thyroiditis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with CAMPATH. Patient recovered.
Cyclophosphamide Side Effects Report #5488092-2
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Oct 05, 2007. Male patient, 40 years of age, was diagnosed with chronic myeloid leukaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, clonus, exophthalmos, headache, hyperreflexia, hypothyroidism, pharyngolaryngeal pain, temperature intolerance, tremor, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with CAMPATH. Patient recovered.
Cyclophosphamide Side Effects Report #5494786-5
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 15, 2007. Female patient, 17 years of age, was diagnosed with chronic myeloid leukaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, headache, hyperthyroidism, hypothyroidism, inflammation, nausea, neck pain, tachycardia, thyroiditis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with CAMPATH. Patient recovered.
Campath Side Effects Report #5465942-7
Consumer or non-health professional from GERMANY reported CAMPATH problem on Sept 14, 2007. Male patient, 40 years of age, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, hyperthyroidism, hypothyroidism, . CAMPATH dosage: 50 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Busulfan Side Effects Report #5469882-9
BUSULFAN problem was reported by a Physician from RUSSIAN FEDERATION on Sept 18, 2007. Female patient was diagnosed with bone marrow conditioning regimen and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, scleroderma, . BUSULFAN dosage: unknown. During the same period patient was treated with FLUDARA, CYCLOSPORINE. Patient recovered.
Busulfan Side Effects Report #5469883-0
Physician from RUSSIAN FEDERATION reported BUSULFAN problem on Sept 18, 2007. Female patient was diagnosed with bone marrow conditioning regimen and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, . BUSULFAN dosage: 8 MG/KG, UNK. During the same period patient was treated with FLUDARA, CYCLOSPORINE. Patient recovered.
Busulfan Side Effects Report #5469902-1
BUSULFAN problem was reported by a Physician from RUSSIAN FEDERATION on Sept 18, 2007. Female patient was diagnosed with bone marrow conditioning regimen and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, sepsis, . BUSULFAN dosage: 8 MG/KG, UNK. During the same period patient was treated with FLUDARA, CYCLOSPORINE. Patient died.
Campath Side Effects Report #5470664-2
Consumer or non-health professional from GERMANY reported CAMPATH problem on Sept 14, 2007. Female patient, 17 years of age, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, hyperthyroidism, hypothyroidism, inflammation, thyroiditis, . CAMPATH dosage: 50 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Busulfex Side Effects Report #5767623-9
BUSULFEX problem was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on May 27, 2008. Male patient, 44 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, cytomegalovirus infection, hepatic enzyme increased, stomatitis, thrombotic microangiopathy, . BUSULFEX dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5777995-7
Consumer or non-health professional from UNITED STATES reported CAMPATH problem on Mar 06, 2008. Female patient, child 9 years of age, was diagnosed with stem cell transplant, graft versus host disease and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, infection, . CAMPATH dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, METHYLPREDNISOLONE. Patient died.
Campath Side Effects Report #5778523-2
CAMPATH problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2008. Female patient, child 9 years of age, was diagnosed with stem cell transplant, graft versus host disease and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, infection, . CAMPATH dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, METHYLPREDNISOLONE. Patient died.
Fludarabine Side Effects Report #5795419-0
Health Professional from TURKEY reported FLUDARABINE PHOSPHATE problem on June 18, 2008. Female patient, 41 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, vitiligo, . FLUDARABINE PHOSPHATE dosage: unknown. During the same period patient was treated with BUSULPHAN, MYCOPHENOLATE MOFETIL. Patient recovered.
Fludarabine Side Effects Report #5690163-2
FLUDARABINE problem was reported by a Consumer or non-health professional from GERMANY on Mar 07, 2008. Female patient was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, diarrhoea, haemolytic uraemic syndrome, infection, mucosal inflammation, nausea, neutropenia, thrombotic thrombocytopenic purpura, . FLUDARABINE dosage: AS USED: 30 MG/M2. During the same period patient was treated with CYTARABINE, AMSACRINE, THYMOGLOBULIN. Patient was hospitalized. Patient died.
Campath Side Effects Report #5697335-1
Consumer or non-health professional from UNITED KINGDOM reported CAMPATH problem on Mar 26, 2008. Male patient, 40 years of age, was diagnosed with chronic myeloid leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, hyperthyroidism, hypothyroidism, . CAMPATH dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Campath Side Effects Report #5697349-1
CAMPATH problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 26, 2008. Female patient, 17 years of age, was diagnosed with chronic myeloid leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, hyperthyroidism, hypothyroidism, inflammation, thyroiditis, . CAMPATH dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Tazocilline Side Effects Report #5285937-6
Health Professional from FRANCE reported TAZOCILLINE problem on Apr 03, 2007. Male patient, 61 years of age, was diagnosed with pyrexia, cytomegalovirus infection and was treated with TAZOCILLINE. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, lacrimation increased, skin necrosis, . TAZOCILLINE dosage: 4 G PIPERACILLIN/500 MG TAZOBACTAM 3 TIMES DAILY. During the same period patient was treated with CANCIDAS, TARGOCID, BRICANYL, ATROVENT, CELLCEPT, VALGANCICLOVIR. Patient was hospitalized. Patient recovered.
Cyclosporine Side Effects Report #5263949-6
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Mar 05, 2007. Male patient, 71 years of age, was diagnosed with stem cell transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, eosinophilia, haemolytic anaemia, pericardial effusion, platelet count decreased, pleural effusion, red blood cell abnormality, renal failure, renal impairment, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient died on 08/01/2005.
Neoral Side Effects Report #5280249-9
Consumer or non-health professional from JAPAN reported NEORAL problem on Mar 22, 2007. Male patient, 71 years of age, was diagnosed with stem cell transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, eosinophilia, haemolytic anaemia, pericardial effusion, platelet count decreased, pleural effusion, red blood cell abnormality, renal failure, renal impairment, . NEORAL dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient died on 08/01/2005.
Cyclosporine Side Effects Report #5618529-7
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Jan 09, 2008. Male patient, child 1 years of age, was diagnosed with stem cell transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, chronic graft versus host disease, cytomegalovirus infection, hyponatraemia, inappropriate antidiuretic hormone secretion, pancreatitis, sepsis, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, CYCLOPHOSPHAMIDE. Patient recovered.
Cyclophosphamide Side Effects Report #5599884-3
Health Professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Jan 22, 2008. Female patient, 39 years of age, was diagnosed with stem cell transplant and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: alopecia, chronic graft versus host disease, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with BUSULFAN. Patient recovered.
Cisplatin Side Effects Report #5541963-0
CISPLATIN problem was reported by a Consumer or non-health professional from JAPAN on Nov 28, 2007. Male patient, 52 years of age, was diagnosed with stem cell transplant and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, chronic graft versus host disease, haemodialysis, haemolytic uraemic syndrome, red blood cell schistocytes present, renal impairment, renal transplant, thrombocytopenia, . CISPLATIN dosage: 25 MG/M2/DAY. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, TACROLIMUS, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Cyclosporine Side Effects Report #5556881-1
Health Professional from JAPAN reported CYCLOSPORINE problem on Dec 03, 2007. Female patient, 17 years of age, was diagnosed with chronic graft versus host disease, scleroderma and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: bedridden, chronic graft versus host disease, cough, dry eye, dyspnoea, forced expiratory volume decreased, hypercapnia, lacrimation decreased, lung transplant, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with RITUXIMAB, TACROLIMUS. Patient was hospitalized. Patient recovered.
Cisplatin Side Effects Report #5570324-3
CISPLATIN problem was reported by a Consumer or non-health professional from JAPAN on Dec 11, 2007. Male patient, 52 years of age, was diagnosed with stem cell transplant and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, chronic graft versus host disease, haemodialysis, haemolytic uraemic syndrome, red blood cell schistocytes present, renal impairment, renal transplant, thrombocytopenia, . CISPLATIN dosage: 25 MG/M2/DAY. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, TACROLIMUS, METHOTREXATE, NEORAL. Patient was hospitalized. Patient recovered.
Cyclophosphamide Side Effects Report #5517637-9
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Nov 08, 2007. Male patient, child 9 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease, acute graft versus host disease, antifungal prophylaxis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, chronic graft versus host disease, haemolysis, haemolytic uraemic syndrome, hypertension, rash maculo-papular, renal failure, sepsis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISONE, CYCLOSPORINE, IMMUNE GLOBULIN INTRAVENOUS, NEUPOGEN, CASPOFUNGIN, PLATELETS. Patient was hospitalized. Patient recovered.
Methotrexate Side Effects Report #5504474-4
METHOTREXATE problem was reported by a Consumer or non-health professional from ISRAEL on Oct 16, 2007. Male patient, 52 years of age, was diagnosed with b precursor type acute leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, chronic graft versus host disease, hepatotoxicity, jaundice cholestatic, leukaemia, no therapeutic response, . METHOTREXATE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYCLOPHOSPHAMIDE, VINCRISTINE, DAUNORUBICIN, ASPARAGINASE, CYTARABINE. Patient recovered.
Campath Side Effects Report #5465941-5
Consumer or non-health professional from GERMANY reported CAMPATH problem on Sept 14, 2007. Female patient, 20 years of age, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: anaemia haemolytic autoimmune, chronic graft versus host disease, hyperthyroidism, . CAMPATH dosage: 50 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYCLOSPORINE. Patient recovered.
Vancomycin Side Effects Report #5466297-4
VANCOMYCIN HYDROCHLORIDE problem was reported by a Health Professional from SWEDEN on Sept 07, 2007. Male patient, child 9. years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with VANCOMYCIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, chronic graft versus host disease, enterococcal infection, haemolytic uraemic syndrome, toxic epidermal necrolysis, . VANCOMYCIN HYDROCHLORIDE dosage: unknown. During the same period patient was treated with ONDANSETRON, CYCLOSPORINE, ACYCLOVIR, FLUCONAZOLE, RANITIDINE, METHYLPREDNISOLONE, NIFEDIPINE. Patient recovered.
Sandimmune Side Effects Report #5379698-X
Consumer or non-health professional from JAPAN reported SANDIMMUNE problem on July 04, 2007. Male patient, child 10 years of age, was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, chronic graft versus host disease, convulsion, depressed level of consciousness, haemorrhage intracranial, neurological symptom, pain in extremity, thrombotic microangiopathy, . SANDIMMUNE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, TACROLIMUS. Patient died.
Sandimmune Side Effects Report #5379891-6
SANDIMMUNE problem was reported by a Consumer or non-health professional from JAPAN on July 04, 2007. Male patient, child 10 years of age, was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, chronic graft versus host disease, convulsion, depressed level of consciousness, haemorrhage intracranial, neurological symptom, pain in extremity, thrombotic microangiopathy, . SANDIMMUNE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, TACROLIMUS. Patient died.
Sandimmune Side Effects Report #5379698-X
Consumer or non-health professional from JAPAN reported SANDIMMUNE problem on July 04, 2007. Male patient, child 10 years of age, was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, chronic graft versus host disease, convulsion, depressed level of consciousness, haemorrhage intracranial, neurological symptom, pain in extremity, thrombotic microangiopathy, . SANDIMMUNE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, TACROLIMUS. Patient died.
Sandimmune Side Effects Report #5379891-6
SANDIMMUNE problem was reported by a Consumer or non-health professional from JAPAN on July 04, 2007. Male patient, child 10 years of age, was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, chronic graft versus host disease, convulsion, depressed level of consciousness, haemorrhage intracranial, neurological symptom, pain in extremity, thrombotic microangiopathy, . SANDIMMUNE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, TACROLIMUS. Patient died.
Prednisolone Side Effects Report #5762115-5
Consumer or non-health professional from UNITED KINGDOM reported PREDNISOLONE problem on May 20, 2008. Female patient, child 10 years of age, was diagnosed with graft versus host disease and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: alopecia, chronic graft versus host disease, gait disturbance, joint contracture, . PREDNISOLONE dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient recovered.
Phenytoin Side Effects Report #5772937-2
PHENYTOIN problem was reported by a Consumer or non-health professional from GERMANY on June 02, 2008. Female patient, child 9 years of age, was diagnosed with convulsion, prophylaxis against graft versus host disease and was treated with PHENYTOIN. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, chronic graft versus host disease, convulsion, . PHENYTOIN dosage: unknown. During the same period patient was treated with FLUCONAZOLE, TACROLIMUS, CYCLOSPORINE, BUSULFAN, FLUDARABINE PHOSPHATE, ANTITHYMOCYTE IMMUNOGLOBULIN. Patient was hospitalized. Patient recovered.
Fludarabine Side Effects Report #5789355-3
Health Professional from AUSTRALIA reported FLUDARABINE PHOSPHATE problem on June 14, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant, prophylaxis against graft versus host disease, antiviral prophylaxis, antifungal prophylaxis and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: cerebral fungal infection, chronic graft versus host disease, . FLUDARABINE PHOSPHATE dosage: unknown. During the same period patient was treated with MELPHALAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, METHOTREXATE, ANTIVIRAL PROPHYLAXIS, COTRIM, FLUCONAZOLE. Patient died.
Prednisolone Side Effects Report #5744842-9
PREDNISOLONE problem was reported by a Health Professional from UNITED KINGDOM on May 13, 2008. Female patient, child 10 years of age, was diagnosed with bone marrow transplant and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: alopecia, chronic graft versus host disease, extremity contracture, gait disturbance, joint contracture, lichenification, scleroderma, skin hyperpigmentation, skin hypopigmentation, . PREDNISOLONE dosage: TEXT:4 MG/KG. During the same period patient was treated with CYCLOSPORINE. Patient recovered.
Fludarabine Side Effects Report #5690052-3
Consumer or non-health professional from UNITED STATES reported FLUDARABINE problem on Mar 07, 2008. Female patient was diagnosed with haematological malignancy and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, chronic graft versus host disease, infection, multi-organ failure, respiratory failure, . FLUDARABINE dosage: TOTAL DAILY DOSE: 160 MG/M2 UNIT DOSE: 160 MG/M2. During the same period patient was treated with MELPHALAN, THIOTEPA, THYMOGLOBULIN. Patient died.
Fludarabine Side Effects Report #5693431-3
FLUDARABINE problem was reported by a Physician from UNITED STATES on Mar 07, 2008. Female patient was diagnosed with myelodysplastic syndrome, prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, chronic graft versus host disease, infection, . FLUDARABINE dosage: TOTAL DAILY DOSE: 25 MG/M2 UNIT DOSE: 25 MG/M2. During the same period patient was treated with BUSULFAN, MELPHALAN, ANTITHYMOCYTE IMMUNOGLOBULIN. Patient died.
Campath Side Effects Report #5697348-X
Consumer or non-health professional from UNITED KINGDOM reported CAMPATH problem on Mar 26, 2008. Female patient, 20 years of age, was diagnosed with chronic myeloid leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: anaemia haemolytic autoimmune, chronic graft versus host disease, hyperthyroidism, . CAMPATH dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYCLOSPORINE. Patient recovered.
Mycophenolate Side Effects Report #5707333-7
MYCOPHENOLATE MOFETIL problem was reported by a Physician from AUSTRIA on Apr 07, 2008. Female patient, child 11 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: aspergillosis, chronic graft versus host disease, cytomegalovirus infection, epstein-barr virus infection, histiocytosis haematophagic, human herpesvirus 6 infection, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with FLUDARABINE, MELPHALAN, ALEMTUZUMAB, PREDNISONE, CYCLOSPORINE. Patient died.
Cyclosporine Side Effects Report #5348881-1
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on June 01, 2007. Male patient, child 10 years of age, was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, chronic graft versus host disease, convulsion, depressed level of consciousness, haemorrhage intracranial, neurological symptom, pain in extremity, thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN. Patient died.
Cyclosporine Side Effects Report #5330790-5
CYCLOSPORINE problem was reported by a Physician from UNITED STATES on May 07, 2007. Male patient, 53 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: basal cell carcinoma, chronic graft versus host disease, malignant melanoma, . CYCLOSPORINE dosage: 3 MG/KG;QD;. During the same period patient was treated with CYCLOPHOSPHAMIDE, DEXAMETHASONE, PREDNISONE, MYCOPHENOLATE MOFETIL. Patient recovered.
Cyclosporine Side Effects Report #5331423-4
Physician from UNITED STATES reported CYCLOSPORINE problem on May 07, 2007. Male patient, 62 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, chronic graft versus host disease, malignant neoplasm progression, squamous cell carcinoma of skin, . CYCLOSPORINE dosage: 3 MG/KG; QD. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, PREDNISONE. Patient died.
Cyclosporine Side Effects Report #5338115-6
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on May 23, 2007. Male patient, child 10 years of age, was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, chronic graft versus host disease, haemorrhage intracranial, thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN. Patient died.
Cyclosporine Side Effects Report #5341247-X
Physician from UNITED STATES reported CYCLOSPORINE problem on May 24, 2007. Male patient, 53 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: basal cell carcinoma, chronic graft versus host disease, malignant melanoma, . CYCLOSPORINE dosage: 3 MG/KG; QD;. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, DEXAMETHASONE, PREDNISONE, MYCOPHENOLATE MOFETIL. Patient recovered.